Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Soheila Korourian

Concepts (300)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1174
2.340
 Why?
Carcinoma, Ductal, Breast
9
2015
89
1.550
 Why?
Mastectomy, Segmental
8
2015
92
1.280
 Why?
Catheter Ablation
4
2014
123
1.100
 Why?
Neoplasm Recurrence, Local
7
2014
614
1.030
 Why?
Sentinel Lymph Node Biopsy
15
2017
116
1.010
 Why?
Mastectomy
10
2018
140
0.970
 Why?
Mammary Neoplasms, Experimental
7
2010
122
0.870
 Why?
Soybean Proteins
4
2023
161
0.840
 Why?
Biopsy, Needle
11
2017
183
0.830
 Why?
Obesity
8
2023
1113
0.820
 Why?
Carcinoma in Situ
3
2008
73
0.800
 Why?
Lymph Nodes
12
2017
260
0.770
 Why?
Caseins
4
2023
80
0.760
 Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
51
0.740
 Why?
Liver
9
2023
1115
0.690
 Why?
DNA, Neoplasm
1
2018
147
0.610
 Why?
Isoflavones
5
2023
89
0.600
 Why?
Rats, Zucker
9
2023
69
0.540
 Why?
Uterine Cervical Neoplasms
3
2007
277
0.500
 Why?
Receptor, erbB-2
3
2018
73
0.490
 Why?
Aged
32
2018
9310
0.480
 Why?
Receptors, Estrogen
4
2018
130
0.460
 Why?
Dietary Supplements
2
2015
443
0.460
 Why?
Arginine
1
2015
179
0.460
 Why?
Middle Aged
34
2018
12069
0.450
 Why?
Female
51
2018
26472
0.440
 Why?
Neoplasm Staging
15
2015
740
0.440
 Why?
Mammary Neoplasms, Animal
2
2015
35
0.410
 Why?
Diet
2
2015
566
0.410
 Why?
Ultrasonography, Mammary
4
2015
60
0.390
 Why?
Fatty Liver
3
2023
127
0.380
 Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.370
 Why?
Carcinogens
3
2015
199
0.370
 Why?
Benz(a)Anthracenes
1
2010
3
0.370
 Why?
Dehydroepiandrosterone
1
2010
15
0.370
 Why?
Rats
15
2023
3305
0.350
 Why?
Axilla
9
2017
89
0.350
 Why?
Aged, 80 and over
15
2018
3129
0.340
 Why?
Lymphatic Vessels
4
2014
48
0.340
 Why?
Adult
25
2018
13236
0.320
 Why?
Plant Lectins
1
2008
8
0.320
 Why?
Prognosis
11
2017
1942
0.320
 Why?
Carcinoma, Ductal
1
2008
9
0.320
 Why?
Magnetic Resonance Imaging
4
2014
1537
0.300
 Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.300
 Why?
Receptors, Progesterone
4
2018
63
0.300
 Why?
Electrosurgery
1
2007
7
0.290
 Why?
Humans
47
2019
49974
0.290
 Why?
Lymphedema
5
2017
43
0.290
 Why?
Thinness
3
2017
46
0.280
 Why?
Lymphatic Metastasis
12
2015
224
0.270
 Why?
Cytodiagnosis
4
2015
42
0.270
 Why?
Prospective Studies
12
2017
2364
0.270
 Why?
Animals
19
2023
13187
0.270
 Why?
Follow-Up Studies
10
2015
2182
0.260
 Why?
Nipples
5
2013
33
0.260
 Why?
Combined Modality Therapy
5
2014
637
0.260
 Why?
Adenocarcinoma, Mucinous
1
2005
19
0.250
 Why?
Endometritis
1
2004
9
0.250
 Why?
Ethanol
5
2010
340
0.240
 Why?
Proteoglycans
1
2004
80
0.240
 Why?
Radiopharmaceuticals
6
2014
209
0.230
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
42
0.230
 Why?
Proliferating Cell Nuclear Antigen
1
2003
75
0.220
 Why?
Laser Coagulation
1
2003
26
0.220
 Why?
Membrane Glycoproteins
1
2004
240
0.220
 Why?
Plasma Cells
1
2004
223
0.220
 Why?
Lymph Node Excision
6
2017
134
0.220
 Why?
Neoplasm Invasiveness
5
2015
267
0.210
 Why?
Carcinoma, Lobular
3
2015
33
0.210
 Why?
Coloring Agents
4
2014
69
0.210
 Why?
Mammaplasty
2
2013
42
0.200
 Why?
Uterine Cervical Dysplasia
3
2007
49
0.200
 Why?
Infant Food
1
2002
29
0.200
 Why?
Biopsy, Fine-Needle
3
2015
103
0.200
 Why?
Monitoring, Intraoperative
3
2014
54
0.190
 Why?
Ovarian Neoplasms
1
2005
447
0.180
 Why?
Immunohistochemistry
9
2017
973
0.180
 Why?
Biopsy
4
2007
584
0.180
 Why?
Ultrasonography, Interventional
3
2011
136
0.180
 Why?
Paraffin Embedding
2
2018
53
0.170
 Why?
Retrospective Studies
13
2015
6108
0.170
 Why?
Body Weight
3
2017
513
0.170
 Why?
Sensitivity and Specificity
8
2015
861
0.170
 Why?
Lung Neoplasms
3
2015
606
0.170
 Why?
Adolescent
8
2015
6356
0.170
 Why?
Neoplasm Grading
3
2014
123
0.170
 Why?
Tissue Fixation
1
2018
36
0.160
 Why?
Specimen Handling
1
2018
55
0.160
 Why?
Alanine Transaminase
3
2015
124
0.150
 Why?
Rats, Sprague-Dawley
7
2015
1597
0.140
 Why?
Treatment Outcome
5
2017
5141
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Protein Hydrolysates
1
2015
6
0.130
 Why?
Aspartate Aminotransferases
1
2015
45
0.130
 Why?
Kaplan-Meier Estimate
2
2014
466
0.130
 Why?
Rosaniline Dyes
1
2014
8
0.120
 Why?
Image-Guided Biopsy
1
2015
33
0.120
 Why?
Sulfotransferases
1
2015
40
0.120
 Why?
Dermatologic Surgical Procedures
2
2013
34
0.120
 Why?
Plant Extracts
1
2017
190
0.120
 Why?
Young Adult
6
2015
3958
0.120
 Why?
Melanoma
2
2011
285
0.120
 Why?
Vacuum
2
2011
13
0.120
 Why?
Ultrasonography, Doppler
1
2014
42
0.120
 Why?
Interleukin-6
1
2015
264
0.120
 Why?
Tumor Necrosis Factor-alpha
1
2015
388
0.110
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.110
 Why?
Intraoperative Care
2
2011
54
0.110
 Why?
Disease-Free Survival
1
2014
454
0.110
 Why?
Preoperative Care
1
2014
164
0.110
 Why?
Skin Neoplasms
2
2011
488
0.100
 Why?
Lymphography
1
2011
9
0.100
 Why?
Image Processing, Computer-Assisted
2
2003
242
0.100
 Why?
Frozen Sections
1
2011
13
0.090
 Why?
Liver Neoplasms
2
2005
326
0.090
 Why?
Male
10
2023
25241
0.090
 Why?
Clinical Competence
1
2013
393
0.090
 Why?
Cytoprotection
1
2010
35
0.090
 Why?
DNA Methylation
1
2015
548
0.090
 Why?
Fatty Liver, Alcoholic
1
2010
7
0.090
 Why?
Drug Evaluation, Preclinical
1
2010
144
0.090
 Why?
Genistein
1
2010
47
0.090
 Why?
Feasibility Studies
1
2011
375
0.090
 Why?
Cell Line, Tumor
3
2010
1403
0.090
 Why?
Hepatocytes
2
2008
182
0.080
 Why?
Pilot Projects
1
2011
699
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
989
0.080
 Why?
Radionuclide Imaging
4
2011
116
0.080
 Why?
Hepatitis
1
2008
21
0.080
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
30
0.080
 Why?
Cytokines
2
2008
612
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
55
0.070
 Why?
Protons
1
2007
69
0.070
 Why?
Ovariectomy
1
2007
119
0.070
 Why?
Organ Size
1
2007
226
0.070
 Why?
Oligosaccharides
1
2005
33
0.070
 Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
 Why?
Antibodies, Neoplasm
1
2005
28
0.060
 Why?
Omentum
1
2005
14
0.060
 Why?
Aging
1
2010
687
0.060
 Why?
Uterine Neoplasms
1
2005
60
0.060
 Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
 Why?
Eosine Yellowish-(YS)
1
2004
5
0.060
 Why?
Carcinoma, Small Cell
1
2004
25
0.060
 Why?
Syndecans
1
2004
34
0.060
 Why?
Hematoxylin
1
2004
7
0.060
 Why?
Syndecan-1
1
2004
72
0.060
 Why?
Endometrium
1
2004
41
0.060
 Why?
Endotoxins
1
2004
34
0.060
 Why?
Immunoenzyme Techniques
1
2004
143
0.060
 Why?
Carbohydrates
1
2004
40
0.060
 Why?
Lymphoma, Non-Hodgkin
1
2004
60
0.060
 Why?
Liver Diseases, Alcoholic
1
2004
35
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Apoproteins
1
2003
14
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
43
0.060
 Why?
Fatty Acids
1
2004
146
0.060
 Why?
Malondialdehyde
1
2003
51
0.060
 Why?
Dietary Fats
1
2004
133
0.060
 Why?
Neoplasms
2
2004
1235
0.060
 Why?
Gene Expression
2
2019
609
0.050
 Why?
Gene Expression Regulation
1
2008
976
0.050
 Why?
Cell Membrane
1
2004
248
0.050
 Why?
Aldehydes
1
2003
83
0.050
 Why?
Risk Factors
1
2011
3613
0.050
 Why?
Cytochrome P-450 CYP2E1
3
2010
113
0.050
 Why?
Overweight
1
2005
219
0.050
 Why?
Surgical Instruments
1
2002
28
0.050
 Why?
Breast Diseases
1
2002
26
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Hematoma
3
2010
64
0.050
 Why?
Asia
1
2002
18
0.050
 Why?
Chronic Disease
1
2004
567
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
318
0.050
 Why?
Head and Neck Neoplasms
1
2004
268
0.050
 Why?
Cost-Benefit Analysis
2
2015
274
0.050
 Why?
Time Factors
1
2007
2903
0.050
 Why?
Neoplasm Metastasis
2
2015
231
0.040
 Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
 Why?
Methyltransferases
1
2019
27
0.040
 Why?
Health Status
1
2002
298
0.040
 Why?
Apoptosis
1
2005
1101
0.040
 Why?
Disease Progression
2
2015
825
0.040
 Why?
Child, Preschool
1
2008
3871
0.040
 Why?
Cohort Studies
2
2015
1422
0.040
 Why?
Alcohol Dehydrogenase
2
2010
38
0.040
 Why?
Oxidative Stress
3
2010
770
0.040
 Why?
Arm
2
2009
47
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Anti-Bacterial Agents
1
2004
744
0.040
 Why?
Polymerase Chain Reaction
1
2019
453
0.040
 Why?
Risk Assessment
2
2017
1259
0.040
 Why?
Disease Models, Animal
2
2015
1455
0.040
 Why?
Feces
1
2017
134
0.040
 Why?
Injections, Intralesional
2
2008
31
0.040
 Why?
Adiponectin
1
2017
64
0.030
 Why?
Reproducibility of Results
2
2015
1193
0.030
 Why?
Phylogeny
1
2017
235
0.030
 Why?
Lipid Metabolism
1
2017
175
0.030
 Why?
Leptin
1
2017
140
0.030
 Why?
Child
1
2008
6847
0.030
 Why?
Cost Savings
1
2015
58
0.030
 Why?
Protective Agents
1
2015
14
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
MCF-7 Cells
1
2015
68
0.030
 Why?
Mice, Inbred BALB C
2
2005
304
0.030
 Why?
Insulin
1
2017
457
0.030
 Why?
CpG Islands
1
2015
108
0.030
 Why?
Infant, Newborn
1
2002
2772
0.030
 Why?
Cyclophosphamide
1
2015
165
0.030
 Why?
Tumor Cells, Cultured
1
2015
465
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Neoadjuvant Therapy
1
2015
114
0.030
 Why?
Biopsy, Large-Core Needle
1
2013
31
0.030
 Why?
Carcinoma
1
2015
138
0.030
 Why?
Infant
1
2002
3567
0.030
 Why?
Angiogenesis Inhibitors
1
2015
187
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
 Why?
Radiotherapy, Adjuvant
1
2013
56
0.030
 Why?
Hormones
1
2013
55
0.030
 Why?
Chemotherapy, Adjuvant
1
2013
119
0.030
 Why?
Injections, Intradermal
1
2011
14
0.030
 Why?
X-Rays
1
2011
55
0.020
 Why?
Antineoplastic Agents
2
2013
1171
0.020
 Why?
United States
1
2002
4860
0.020
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Intraoperative Period
1
2011
45
0.020
 Why?
Diagnosis, Differential
2
2004
1037
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2015
828
0.020
 Why?
Predictive Value of Tests
2
2004
903
0.020
 Why?
Allyl Compounds
1
2010
10
0.020
 Why?
Sulfides
1
2010
28
0.020
 Why?
Survival Rate
1
2012
894
0.020
 Why?
Chemokines
1
2010
77
0.020
 Why?
Double-Blind Method
1
2011
681
0.020
 Why?
Transforming Growth Factor beta1
1
2010
60
0.020
 Why?
Mammary Glands, Animal
1
2010
69
0.020
 Why?
Cell Division
1
2010
292
0.020
 Why?
Endoplasmic Reticulum
1
2010
108
0.020
 Why?
Pyrazoles
1
2010
113
0.020
 Why?
Tissue Extracts
1
2007
13
0.020
 Why?
Least-Squares Analysis
1
2007
43
0.020
 Why?
Pregnancy
1
2015
2607
0.020
 Why?
Biotransformation
1
2007
86
0.020
 Why?
Electrocoagulation
1
2007
12
0.020
 Why?
Enzyme Inhibitors
1
2010
391
0.020
 Why?
Survival Analysis
1
2009
653
0.020
 Why?
Solubility
1
2007
69
0.020
 Why?
Observer Variation
1
2007
130
0.020
 Why?
Enteral Nutrition
1
2008
147
0.020
 Why?
Staining and Labeling
1
2007
97
0.020
 Why?
Positron-Emission Tomography
1
2008
295
0.020
 Why?
E-Selectin
1
2005
15
0.020
 Why?
Body Weights and Measures
1
2005
17
0.020
 Why?
Wheat Germ Agglutinins
1
2005
3
0.020
 Why?
Vaccines, Subunit
1
2005
15
0.020
 Why?
Vaccines, DNA
1
2005
11
0.020
 Why?
Gadolinium
1
2005
43
0.020
 Why?
Cross Reactions
1
2005
42
0.020
 Why?
Cytotoxicity, Immunologic
1
2005
54
0.020
 Why?
Growth Inhibitors
1
2005
27
0.020
 Why?
Gene Amplification
1
2005
57
0.020
 Why?
Ligands
1
2005
204
0.020
 Why?
Mice
2
2005
5739
0.020
 Why?
Glucose Transporter Type 1
1
2004
17
0.020
 Why?
Imaging, Three-Dimensional
1
2005
151
0.020
 Why?
Free Radicals
1
2004
28
0.020
 Why?
Sampling Studies
1
2004
37
0.020
 Why?
Enzyme Induction
1
2004
80
0.010
 Why?
In Situ Hybridization, Fluorescence
1
2005
259
0.010
 Why?
Corn Oil
1
2004
12
0.010
 Why?
Hyperplasia
1
2004
96
0.010
 Why?
Eye Neoplasms
1
2004
10
0.010
 Why?
MART-1 Antigen
1
2004
12
0.010
 Why?
Contrast Media
1
2005
184
0.010
 Why?
Species Specificity
1
2004
192
0.010
 Why?
Amino Acid Sequence
1
2005
585
0.010
 Why?
Injections
1
2003
55
0.010
 Why?
Necrosis
1
2004
176
0.010
 Why?
Dietary Carbohydrates
1
2004
88
0.010
 Why?
Rats, Wistar
1
2004
223
0.010
 Why?
Cell Proliferation
1
2008
1007
0.010
 Why?
Molecular Sequence Data
1
2005
792
0.010
 Why?
Cytoplasm
1
2004
90
0.010
 Why?
Regression Analysis
1
2004
395
0.010
 Why?
Energy Intake
1
2004
170
0.010
 Why?
Cytochrome P-450 Enzyme System
1
2004
195
0.010
 Why?
Cell Nucleus
1
2004
183
0.010
 Why?
Antigens, Neoplasm
1
2004
151
0.010
 Why?
Multivariate Analysis
1
2004
577
0.010
 Why?
Glutathione
1
2004
295
0.010
 Why?
Sex Characteristics
1
2004
190
0.010
 Why?
Antioxidants
1
2004
249
0.010
 Why?
Confidence Intervals
1
2002
156
0.010
 Why?
Models, Theoretical
1
2002
175
0.010
 Why?
Neoplasm Proteins
1
2004
322
0.010
 Why?
Reoperation
1
2002
454
0.010
 Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (300) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department